Post-Stroke Shoulder Pain Reduced with Peripheral Nerve Stimulator

Clinical results reported at the 2017 North American Neuromodulation Society meeting show that peripheral nerve stimulation can help stroke patients. And that peripheral nerve stimulation provides meaningful relief for people suffering from post-stroke shoulder pain (PSSP). Post stroke shoulder pain is experienced by anywhere between 30 and 70 percent of stroke sufferers. Dr. Porter McRoberts is a trained Physiatrist and Interventional Spine and Pain Management Specialist in Fort Lauderdale, Florida. He shared data indicating that peripheral nerve stimulation is a promising treatment for post-stroke shoulder pain (PSSP) patients. When compared to the alternative options for pain management, it proved helpful.…
Read More

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation

Dr. Brian M. Ilfeld, MD, MS, feels this strongly about the potential for ultrasound-guided percutaneous peripheral nerve stimulation. It's a technology that he says has the potential to forever change the way anesthesiologists treat acute postoperative pain. He discussed the results of a prospective feasibility study. As well as the potential for the technology’s future—at the 2016 annual Regional Anesthesiology and Acute Pain Medicine meeting (abstract A1265). Gradually, a Technique Emerges “There were very early reports of using electricity applied cutaneously to provide analgesia following surgical procedures,” said Dr. Ilfeld. He is a professor of anesthesiology in residence at the…
Read More

Electrical Nerve Stimulation Device Prevents Migraine

Study shows 81% reduction in number of migraine days per month with electrical nerve stimulation In a new study, Cefaly, the first FDA-approved transcutaneous electrical nerve-stimulation device for use before onset of migraine pain. It was shown to have provided relief for 81% of migraine patients who used it. The study, conducted in Italy, enrolled 24 patients with migraine without aura. These patients were experiencing a low number of attacks per month and who had taken migraine-preventive drugs. The primary outcome measures were the reductions in migraine attacks and in the number of migraine days per month. Then investigators also…
Read More